MK-8353: Discovery of an Orally Bioavailable Dual Mechanism ERK Inhibitor for Oncology
MK-8353:一种用于肿瘤治疗的口服生物利用度高的双机制ERK抑制剂的发现
期刊:ACS Medicinal Chemistry Letters
影响因子:4
doi:10.1021/acsmedchemlett.8b00220
Boga, Sobhana Babu; Deng, Yongqi; Zhu, Liang; Nan, Yang; Cooper, Alan B; Shipps, Gerald W Jr; Doll, Ronald; Shih, Neng-Yang; Zhu, Hugh; Sun, Robert; Wang, Tong; Paliwal, Sunil; Tsui, Hon-Chung; Gao, Xiaolei; Yao, Xin; Desai, Jagdish; Wang, James; Alhassan, Abdul Basit; Kelly, Joseph; Patel, Mehul; Muppalla, Kiran; Gudipati, Subrahmanyam; Zhang, Li-Kang; Buevich, Alexei; Hesk, David; Carr, Donna; Dayananth, Priya; Black, Stuart; Mei, Hong; Cox, Kathleen; Sherborne, Bradley; Hruza, Alan W; Xiao, Li; Jin, Weihong; Long, Brian; Liu, Gongjie; Taylor, Stacey A; Kirschmeier, Paul; Windsor, William T; Bishop, Robert; Samatar, Ahmed A